newsfilter
← Latest News
GlobeNewswire·

Satsuma Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

Completed treatment phase of pivotal EMERGE™ Phase 3 efficacy trial of STS101 as planned and remain on track to report top-line results in late September or early October 2020Initiated patient...